Study of the effect of pitavastatin on glucose and lipid metabolism abnormality after the test meal loading.

Study of the effect of pitavastatin on glucose and lipid metabolism abnormality after the test meal loading. - Study of the effect of pitavastatin on glucose and lipid metabolism abnormality after the test meal loading.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011405

Enrollment

Registered

2013-08-08

Start date

2013-08-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal obesity patients with dyslipidemia.

Interventions

LIVALO (Pitavastatin Calcium)

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Men with abdominal obesity and dyslipidemia, aged 30 - 75 yr. 2. Outpatients. 3. Patients who will be able to obtain written informed consent. 4. Patient's waist circumference >= 85cm. 5. Patients who satisfy at least one of the following: TC >= 220mg/dL, TG >= 150mg/dL, HDL-cholesterol < 40mg/dL.

Exclusion criteria

Exclusion criteria: 1. Patients with secondary dyslipidemia. 2. Patients who have a history of severe side effects due to statin. 3. Patients with severe liver failure and/or renal failure. 4. Patients who are taking cyclosporine. 5. Patients with food allergy due to test meal component. 6. Patients who were judged to be inappropriate for the study by the investigator.

Design outcomes

Primary

Measure	Time frame
Oxidative stress markers of before and after test meal loading. (isoprostane, 8-OHdG) Renal function.	—

Countries

Japan

Contacts

Public ContactJunji Kobayashi

Kanazawa Medical University General Internal Medicine

mary@kanazawa-med.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026